If you made any changes in Pure, your changes will be visible here soon.

Fingerprint The Fingerprint is created by mining the titles and abstracts of the person's research outputs and projects/funding awards to create an index of weighted terms from discipline-specific thesauri.

  • 4 Similar Profiles
Prostatic Neoplasms Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Urinary Bladder Neoplasms Medicine & Life Sciences
Kidney Neoplasms Medicine & Life Sciences
Immunotherapy Medicine & Life Sciences
Renal Cell Carcinoma Medicine & Life Sciences
Drug Therapy Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Projects 2011 2027

Renal Cell Carcinoma
Interleukin-2
Neoplasms
nivolumab
Androgen Receptors
Urinary Bladder Neoplasms
MDV 3100
Neoplasms
Therapeutics
Poly Adenosine Diphosphate Ribose
Safety
Neoplasms
avelumab
talazoparib
Renal Cell Carcinoma

Research Output 2007 2019

Abiraterone acetate in combination with androgen deprivation therapy compared to androgen deprivation therapy only for metastatic hormone-sensitive prostate cancer

Sathianathen, N. J., Dahm, P., Brown, S. J., Oestreich, M., Gupta, S., Konety, B. R. & Kunath, F., Jan 24 2019, In : Cochrane Database of Systematic Reviews. 2019, 1, CD013245.

Research output: Contribution to journalArticle

Androgens
Prostatic Neoplasms
Hormones
Therapeutics
Abiraterone Acetate
9 Citations

Efficacy and safety of pembrolizumab in recurrent/metastatic head and neck squamous cell carcinoma: Pooled analyses after long-term follow-up in KEYNOTE-012

Mehra, R., Seiwert, T. Y., Gupta, S., Weiss, J., Gluck, I., Eder, J. P., Burtness, B., Tahara, M., Keam, B., Kang, H., Muro, K., Geva, R., Chung, H. C., Lin, C. C., Aurora-Garg, D., Ray, A., Pathiraja, K., Cheng, J., Chow, L. Q. M. & Haddad, R., Jul 17 2018, In : British Journal of Cancer. 119, 2, p. 153-159 7 p.

Research output: Contribution to journalArticle

Safety
Therapeutics
Carcinoma, squamous cell of head and neck
pembrolizumab
Survival

FDG-PET/CT for Assessing the Response to Neoadjuvant Chemotherapy in Bladder Cancer Patients

Soubra, A., Gencturk, M., Froelich, J. W., Balaji, P., Gupta, S., Jha, G. & Konety, B. R., Oct 1 2018, In : Clinical Genitourinary Cancer. 16, 5, p. 360-364 5 p.

Research output: Contribution to journalArticle

Urinary Bladder Neoplasms
Drug Therapy
Cystectomy
Muscles
Sensitivity and Specificity

Immunotherapy Advances in Urothelial Carcinoma

Jain, R. K., Snyders, T., Nandgoapal, L., Garje, R., Zakharia, Y. & Gupta, S., Dec 1 2018, In : Current treatment options in oncology. 19, 12, 79.

Research output: Contribution to journalReview article

Immunotherapy
Carcinoma
Platinum
Cisplatin
Therapeutics
1 Citations

PD1/PDL1 inhibitors for the treatment of advanced urothelial bladder cancer

Stenehjem, D. D., Tran, D., Nkrumah, M. A. & Gupta, S., Jan 1 2018, In : OncoTargets and Therapy. 11, p. 5973-5989 17 p.

Research output: Contribution to journalReview article

Urinary Bladder Neoplasms
Immunotherapy
Therapeutics
Biomarkers
Platinum